- 4009 Hackney Springs Ln, Sachse, TX 75048
Master Delaware Medicaid, Medicare, Highmark Blue Cross Blue Shield Delaware & 75+ Commercial Payer Requirements
Slash Claim Denials by 35% with CPT/HCPCS Code Precision
Navigate Delaware's Concentrated Payer Market and MCO Requirements
Post Payments in 24-48 Hours—Zero Revenue Bottlenecks
Recover Outstanding A/R in 30 Days—42% Faster Than Industry Average
Highmark Blue Cross Blue Shield dominates Delaware with 70% market share, creating intense pressure on reimbursement rates and strict medical necessity requirements. A payer relationship failure impacts 70-80% of commercial revenue.
| Medicare Administrative Contractor (MAC) | Jurisdiction Code | MolDX Program Participant |
|---|---|---|
| Novitas Solutions | Jurisdiction L (JL) | No (Independent LCDs) |
In Delaware, laboratory billing is administered through Novitas Solutions Jurisdiction L. Revenue cycle management protocols must strictly observe Novitas’ regional coverage policies. Key compliance focus areas include proper handling of reflex testing workflows, avoiding unbundled CPT coding for automated multi-channel chemistry profiles, and maintaining audit-ready physician orders for all reference testing.
First-pass clean claim rates of 98%
Denial rates below 3%
Days in A/R reduced from 78+ days to under 21 days
Overall revenue improvement of 8-12%
Denials reduced by 35%
AAPC/AHIMA certified coders ensure precise CPT, ICD-10, and HCPCS code assignment across all laboratory specialties. Accurate coding reduces denials, accelerates payments, and keeps your lab fully compliant with evolving payer requirements
Complete payer enrollment, CLIA certification management, and network participation setup across all insurance carriers. TransLabs manages every credentialing detail so that your laboratory gets paid in-network from day one without any administrative delays.
Real-time insurance verification, benefits investigation, and prior auth completed before specimen processing begins. Confirming coverage upfront eliminates preventable denials and protects your lab from unexpected reimbursement failures.
Patient registration, appointment coordination, insurance verification, and customer service excellence managed by experienced laboratory billing professionals. A well-run front office reduces downstream billing errors and creates a better experience.
Our labs billing services adhere strictly to CMS Laws and HIPAA guidelines
We code to Novitas Solutions's current LCDs; before the denial, not after.
Delaware Medical Assistance Program coverage changes flagged before they cost you a claim.
Denial-trend data from the payers common across Delaware.
One person who owns your account, start to finish.
No contracts to sign. Live within 24 hours.
TransLabs specializes exclusively in Delaware laboratory facilities, giving us unmatched expertise in Delaware Medicaid MCO requirements, Highmark BCBS Delaware policies, Medicare Administrative Contractor (MAC) Jurisdiction L (JL) requirements, multi-state patient coordination, and Delaware-specific payer regulations. Our 98% first-pass clean claim rate and 99% client retention rate reflect our commitment to excellence.
Delaware’s statute of limitations for medical billing is generally three years from the date of service. However, insurance companies have much shorter filing deadlines; typically 90 to 180 days for commercial payers, 365 days for Medicare, and 6-12 months for Delaware Medicaid MCOs. Missing these deadlines forfeits your right to payment, which is why timely claim submission is critical.
Yes, all three Delaware Medicaid MCOs (AmeriHealth Caritas Delaware, Highmark Health Options, and United Healthcare Community Plan) require prior authorization for molecular diagnostics, genetic testing, most tests over $500, and specialty immunology panels. Authorization requirements and processes vary by MCO. The authorization process typically takes 9-24 days depending on the MCO, complexity, and medical necessity documentation. TransLabs manages all three MCO portals to ensure approvals are secured before testing begins.
A Local Coverage Determination (LCD) is a Medicare policy that defines which tests are covered, which ICD-10 codes support medical necessity, and testing frequency limitations. Delaware falls under Medicare Administrative Contractor (MAC) Jurisdiction L (JL), administered by Novitas Solutions, which has strict LCDs for molecular and genetic testing. Billing a test with a non-covered diagnosis code results in automatic denial and potential audit exposure.
We pre-verify medical necessity before testing, submit prior authorizations with comprehensive documentation to the appropriate Delaware Medicaid MCO or commercial payer, use LCD-compliant diagnosis coding, attach required medical records, and proactively communicate with payers to prevent denials. We maintain specialized expertise in Highmark BCBS Delaware’s requirements given their market dominance. For denied claims, we submit detailed appeals with peer-reviewed literature and clinical guidelines. Our molecular/genetic testing claim acceptance rate is 98%.
